Orthotopic, Bioluminescent Syngeneic HCC Models Developed

Hepatocellular carcinoma (HCC) is an aggressive cancer type with limited therapeutic treatment options. Immunotherapies such as checkpoint inhibitors are being evaluated in HCC, which therefore require suitable models for thorough preclinical development.